Concepedia

Mark Hill

MH

87

Publications

7.6K

Citations

42

H-Index

1967

Active since

Affiliations

Royal Marsden Hospital(Current)

Royal Marsden NHS Foundation Trust

Maidstone Hospital

Royal Bournemouth Hospital

University of Pennsylvania

Mark Hill is an author at Royal Marsden Hospital specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1967–2023

87

Publications

87

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

Daniel G. Haller, Josep Tabernero, Jean A. Maroun et al. · Journal of Clinical Oncology · 2011 · 774 citations · Full text

Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer

Ian Chau, Gina Brown, David Cunningham et al. · Journal of Clinical Oncology · 2006 · 477 citations · Full text

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

Sarah Brown, Gary Middleton, Tim Maughan et al. · The Lancet Oncology · 2013 · 388 citations · Full text

Skin Color and the Perception of Attractiveness among African Americans: Does Gender Make a Difference?

Mark Hill · Social Psychology Quarterly · 2002 · 368 citations

, , +20

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

Hans‐Joachim Schmoll, Thomas H. Cartwright, Josep Tabernero et al. · Journal of Clinical Oncology · 2006 · 296 citations

Rows per page

1–5 of 87